↓ Skip to main content

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Overview of attention for article published in Frontiers in Cardiovascular Medicine, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension
Published in
Frontiers in Cardiovascular Medicine, February 2022
DOI 10.3389/fcvm.2022.810262
Pubmed ID
Authors

Zhengqing Ba, Ying Xiao, Ming He, Dong Liu, Hao Wang, Hanyang Liang, Jiansong Yuan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 14%
Unspecified 1 5%
Other 1 5%
Student > Bachelor 1 5%
Student > Doctoral Student 1 5%
Other 2 9%
Unknown 13 59%
Readers by discipline Count As %
Medicine and Dentistry 5 23%
Nursing and Health Professions 1 5%
Unspecified 1 5%
Neuroscience 1 5%
Materials Science 1 5%
Other 0 0%
Unknown 13 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2022.
All research outputs
#18,795,369
of 23,292,144 outputs
Outputs from Frontiers in Cardiovascular Medicine
#3,368
of 7,189 outputs
Outputs of similar age
#316,110
of 438,840 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#445
of 943 outputs
Altmetric has tracked 23,292,144 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,189 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,840 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 943 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.